Independent Evaluation of Two Prototype Immunochromatographic Tests for Dengue Fever Developed by InBios
Abstract
Dengue fever, caused by any of the four dengue viruses (DENV1–4), is endemic in more than 100 countries around the world. Each year, up to 400 million people get infected with dengue virus. It is one of the most important arthropod-borne viral diseases. Dengue’s global presence poses a medical threat to deploying military personnel and their dependents. An accurate diagnosis followed by attentive supportive care can improve outcomes in patients with severe dengue disease. Dengue diagnostic tests based on PCR and ELISA platforms have been developed and cleared by the U.S. FDA. However, these diagnostic assays are laborious and usually require highly trained personnel and specialized equipment, which presents a significant challenge when conducting operations in austere and resource-constrained areas. InBios International, Inc. (Seattle, WA) has developed two rapid and instrument-free immunochromatographic test prototype devices (multiplex and traditional formats) for dengue diagnosis.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 11, 2021
- Source ID
- 10.1093/milmed/usaa553
Entities
People
- Calli M Rooney
- Cheng-rei Lee
- Damon W Ellison Phd
- Gabriel N Defang Phd
- Hua-wei Chen
- Marshall Van De Wyngaerde
- Maya Williams Phd
- Shuenn-jue L. Wu
- Tania D Maldonado
Organizations
- Naval Medical Research Center
- Walter Reed Army Institute of Research